SPIN Unprocessed October 26, 2026 ai_technology finance
Kos Biotechnology Partners Announces Strategic Investment in Golden Age Health to Accelerate Global Access to Rare Disease Therapies
View original on prnewswire.comOverview
Golden Age Health is co-founded and chaired by Michel Vounatsos, former Biogen CEO and Merck President NEW YORK and ATHENS, Greece and SINGAPORE, Oct. 26, 2026 /PRNewswire/ -- Kos Biotechnology Partners ("Kos"), a global life sciences investment firm bridging the U.S. and European...
SpinGraph analysis pending — check back after processing.
Ask AI about this story
Opens with the SpinGraph .md URL and structured context — one click, prompt included.
More from PR Newswire Financial Services
View all →- FP Markets: Healeys erster Haushaltsplan rückt britische Staatsanleihen in den Fokus
- Perpetua Resources Awarded Up to $40 Million in U.S. Army Funding to Advance Domestic Tungsten Supply for American Defense
- Kansas City Life Declares Quarterly Dividend
- First Horizon Declares Cash Dividends on Common and Preferred Stock
- SKX Stockholder Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against Skechers U.S.A., Inc.
- New electrification index shows China out front as US risks stalling and Europe's policies outpace delivery
Markdown (.md) · JSON-LD schema (.json) · Machine-readable for AI & GEO